Compare ACN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACN | ABT |
|---|---|---|
| Founded | 1989 | 1888 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.4B | 222.8B |
| IPO Year | N/A | N/A |
| Metric | ACN | ABT |
|---|---|---|
| Price | $273.18 | $127.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 18 |
| Target Price | ★ $301.05 | $146.61 |
| AVG Volume (30 Days) | 4.0M | ★ 6.7M |
| Earning Date | 12-18-2025 | 01-21-2026 |
| Dividend Yield | ★ 2.40% | 1.86% |
| EPS Growth | 6.28 | ★ 141.97 |
| EPS | ★ 12.15 | 7.96 |
| Revenue | ★ $69,672,977,000.00 | $43,843,000,000.00 |
| Revenue This Year | $6.73 | $7.56 |
| Revenue Next Year | $5.40 | $7.96 |
| P/E Ratio | $22.39 | ★ $15.94 |
| Revenue Growth | ★ 7.36 | 6.37 |
| 52 Week Low | $229.40 | $110.86 |
| 52 Week High | $398.35 | $141.23 |
| Indicator | ACN | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 64.22 | 52.58 |
| Support Level | $265.01 | $120.70 |
| Resistance Level | $277.65 | $129.64 |
| Average True Range (ATR) | 6.79 | 2.31 |
| MACD | 1.17 | 0.26 |
| Stochastic Oscillator | 74.69 | 70.49 |
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.